CVE-2024-1200

Public Exploit
Jspxcms information disclosure

Description

A vulnerability was found in Jspxcms 10.2.0 and classified as problematic. Affected by this issue is some unknown functionality of the file /template/1/default/. The manipulation leads to information disclosure. The attack may be launched remotely. The exploit has been disclosed to the public and may be used. VDB-252698 is the identifier assigned to this vulnerability.

Category

5.3
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.09%
Third-Party Advisory vuldb.com Third-Party Advisory vuldb.com
Affected: n/a Jspxcms
Published at:
Updated at:

References

Link Tags
https://vuldb.com/?id.252698 third party advisory vdb entry
https://vuldb.com/?ctiid.252698 signature third party advisory vdb entry permissions required
https://github.com/sweatxi/BugHub/blob/main/Nanchang%20Lanzhi%20Technology%20Co.pdf exploit

Frequently Asked Questions

What is the severity of CVE-2024-1200?
CVE-2024-1200 has been scored as a medium severity vulnerability.
How to fix CVE-2024-1200?
To fix CVE-2024-1200, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-1200 being actively exploited in the wild?
It is possible that CVE-2024-1200 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-1200?
CVE-2024-1200 affects n/a Jspxcms.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.